NCT05930457 2023-12-26
Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
The First Affiliated Hospital of Guangzhou Medical University
Phase 1 Completed
Clinical Trials
4 trialsNCT05814835 2023-12-20
First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
Chinese PLA General Hospital
Phase 1 Completed
NCT01391533 2016-04-13
SARMET
Sanofi
Phase 1 Completed
NCT00516438 2010-12-08
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan
AstraZeneca
Phase 1 Completed